ACTRN12621000281897已完成2 期
A prospective study of the renal effects of angiotensin II management in critically ill patients with distributive shock
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Adults aged > 18 years
- •Vasodilatory shock (MAP <65 mmHg)
- •Central venous access and an arterial line present
- •Indwelling urinary catheter
- •Expected to require vasopressor support for at least 24 hours
- •Informed consent provided by the patient or medical treatment decision-maker
排除标准
- •Cardiac surgery patients
- •>24 hours noradrenaline or metaraminol prior to enrolment
- •Chronic haemodialysis or peritoneal dialysis
- •Not receiving venous thromboembolism prophylaxis
- •Venous thromboembolism or pulmonary embolus in the last 6 months
- •Expected survival <24 hours
- •Suspected or confirmed pregnancy
研究者
相似试验
已完成
不适用
Renal toxicity during cancer treatment with angiogenesis inhibitorsPodocyturia as a possible early marker of renal toxicity during angiogenesis inhibitionNL-OMON29589Dr. M.H.W. Kappers, Amphia hospital Breda90
招募中
不适用
Examination of the effects on renal function and prognosis of various diuretics for liver cirrhosisiver cirrhosisJPRN-UMIN000040179Hokkaido University400
尚未招募
不适用
Study of renal function renal protective effect of cooling method in laparoscopic partial nephrectomyRenal cell cacinomaJPRN-UMIN000013867Kansai Medical University30
进行中（未招募）
1 期
Evaluation of the impact of renal function on the pharmacokinetics of hydroxyurea (Siklos®) in patients with sickle cell disease with normal renal function, with hyperfiltration, or with renal failure. DARH studySiklos is indicated for the prevention of recurrent painful vaso-occlusive crises including acute chest syndrome in adults, adolescents and children older than 2 years suffering from symptomatic sickle cell syndrome.MedDRA version: 17.1Level: LLTClassification code 10040643Term: Sickle cell crisisSystem Organ Class: 100000004851EUCTR2014-005033-31-FRAddmedica S.A.S
已完成
不适用
The investigation of the renal protective effect of Carperitide(hANP:human atrial natriuretic peptide) during adult living donor renal transplantation, a single center experience.living donor renal transplantationJPRN-UMIN000014279Toho University School of Medicine, Department of Anesthesiology30